Our observations revealed that, albeit the scAAV9_MCP1 i.m. injection boosted the chemokine to the same extent along the neuromuscular system of the 2 ALS models, the treatment led to an opposite effect on the clinical phenotype of C57 compared with 129Sv mSOD1 mice. Here, CCL2 is linked to amyotrophic lateral sclerosis.